---
DrugClass: "[[Antiparkinson]]"
SubClass: "[[Dopamine Receptor Agonists, Nonergot]]"
DrugClassContra: "[[Dopamine Receptor Agonists, Nonergot#Contraindications]]"
DrugClassAdverse: "[[Dopamine Receptor Agonists, Nonergot#Adverse Reactions]]"
SecondarySubClass: 
BrandName: Mirapex
Chapter: "27"
KindleLinkChap: "[Chapter 27](kindle://book?action=open&asin=B09FRF11YJ&location=14154)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
CCCN[C@H]1CCC2=C(C1)SC(=N2)N
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Parkinson disease, restless leg syndrome (RLS) 
0.125â€“ 1.5 mg orally TID 

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Dizziness, [[somnolence]], insomnia, hallucinations, confusion, nausea, [[Dyspepsia]], syncope 

### Interactions

`= this.ChemLink+this.file.name`

